We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Pasireotide‐induced hyperglycemia in a patient with Cushing's disease: Potential use of sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist for treatment.
- Authors
Shikata, Masato; Ashida, Kenji; Goto, Yuka; Nagayama, Ayako; Iwata, Shimpei; Yano, Mamiko; Hasuzawa, Nao; Hara, Kento; Mawatari, Kazutoshi; Sakata, Kiyohiko; Tsuruta, Munehisa; Wada, Nobuhiko; Nomura, Masatoshi
- Abstract
Pasireotide improves hypercortisolemia and induces hyperglycemia via somatostatin receptor type‐5 stimulation. GLP‐1RA and SGLT2 inhibitor potentially help regulate hyperglycemia in patients with Cushing's disease, especially after pasireotide administration.
- Subjects
GLUCAGON-like peptide-1 receptor; SODIUM-glucose cotransporter 2 inhibitors; CUSHING'S syndrome; GLUCAGON-like peptide-1 agonists; HYPERGLYCEMIA; SOMATOSTATIN receptors
- Publication
Clinical Case Reports, 2020, Vol 8, Issue 12, p2613
- ISSN
2050-0904
- Publication type
Article
- DOI
10.1002/ccr3.3230